Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000906344-09-000207
Filing Date
2009-02-10
Accepted
2009-02-10 15:25:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCH 13G/A1 (02/10/09) celltherapeutics_13g-a1.htm SC 13G/A 66044
  Complete submission text file 0000906344-09-000207.txt   67760
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Subject) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48459 | Film No.: 09585546
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE FERRY BUILDING, SUITE 255 SAN FRANCISCO CA 94111
Business Address (415) 677-1577
Levine Mitchell S (Filed by) CIK: 0001383492 (see all company filings)

Type: SC 13G/A